Equities

Greenbrook Tms Inc

GBNHF:QBB

Greenbrook Tms Inc

Actions
  • Price (USD)0.02
  • Today's Change-0.004 / -16.32%
  • Shares traded224.18k
  • 1 Year change-91.61%
  • Beta1.4457
Data delayed at least 15 minutes, as of Nov 12 2024 20:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Greenbrook TMS Inc. is a provider of Transcranial Magnetic Stimulation (TMS) therapy and Spravato (esketamine nasal spray), non-invasive therapies for the treatment of Major Depressive Disorder (MDD) and other mental health disorders. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. The Company operates a network of outpatient mental health service centers that specialize in treatment across the United States. It offers Treatment Centers in convenient locations to provide easy access to patients and clinicians. The Company owns and operates 130 Treatment Centers in the Commonwealths of Massachusetts, Virginia and Pennsylvania and the States of Maryland, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, and Michigan.

  • Revenue in USD (TTM)75.21m
  • Net income in USD-52.20m
  • Incorporated2018
  • Employees629.00
  • Location
    Greenbrook Tms Inc890 Yonge St 7th FloorTORONTO M4W 3P4CanadaCAN
  • Phone+1 (416) 322-9700
  • Fax+1 (416) 322-9700
  • Websitehttps://www.greenbrooktms.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
IMAC Holdings Inc0.00-5.63m2.00m2.00---------5.04-5.460.00-1.080.00--0.000.00-166.65-48.88-1,050.71-70.25-------97.63---14.97--------45.27------
Mitesco Inc6.00k-4.15m2.16m3.00------360.32-0.6434-0.61210.0004-2.540.0332----2,000.00-1,094.48-246.54----0.00---33,009.50-29,214.62---0.7877---------59.12------
Modern Mobility Aids Inc0.00-1.59m2.75m-----------0.0177-0.01770.00-0.0040.00-------4,668.68---------------------------371.94------
Avalon Globocare Corp1.30m-14.54m3.37m5.00------2.60-19.80-19.801.765.760.0517--11.49259,018.00-58.06-100.94-81.85-134.5117.2124.44-1,122.68-1,011.06---0.41680.6497--4.45-4.28-40.03---51.83--
Greenbrook TMS Inc75.21m-52.20m3.37m629.00------0.0448-1.20-1.201.72-2.711.33--8.73---93.25-68.51-206.71-106.4528.2738.65-70.09-76.82---1.9920.04--10.4228.2644.21---54.79--
Biocorrx Inc36.76k-4.29m3.48m5.00------94.80-0.4837-0.48370.0042-1.120.0595--0.3422---697.45-291.68----49.4067.13-11,718.77-3,208.40---2.96-----58.31-25.0413.79------
Syra Health Corp7.74m-4.25m3.87m78.00--1.16--0.5004-0.6471-0.64711.160.33962.20--7.9899,250.77-120.88---225.30--22.99---54.90-----5,665.830.0673---1.83---38.72------
Selectis Health Inc37.33m-6.17m4.17m574.00------0.1118-2.02-2.0212.19-1.050.8922--15.6765,027.49-14.67-3.03-25.30-3.58-----16.44-4.84---2.981.11---9.4058.97-64.93---47.72--
Medical Care Technologies Inc.0.00-1.07m4.30m0.00---------553,570.10-553,570.100.00-389.230.00-------154.94-----------------1.46---------40.06------
CompuMed Inc1.78m-151.00k4.81m8.00--36.94--2.70-0.1337-0.13371.580.09972.3836.714.83---19.92-46.77-48.38-76.7850.4257.04-8.38-25.840.9493-2.930.7744---1.73-5.7164.41---18.75--
Mangoceuticals Inc866.79k-9.13m4.86m----0.3427--5.61-6.58-6.580.61527.120.093519.32-----98.48---107.62--58.19---1,052.90--0.3653-38.860.0134--8,082.22---361.07------
Data as of Nov 12 2024. Currency figures normalised to Greenbrook Tms Inc's reporting currency: US Dollar USD

Institutional shareholders

2.51%Per cent of shares held by top holders
HolderShares% Held
AdvisorShares Investments LLCas of 04 Oct 20241.15m2.51%
Desjardins Securities, Inc.as of 30 Jun 20240.000.00%
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.